WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear ...

Global efforts at ending the HIV pandemic by 2030 have stalled. There still are more than 30,000 new infections in the U.S. each year and about 1.3 million worldwide.

WHO has officially recommended twice-yearly injectable lenacapavir for HIV prevention, marking a major shift in global HIV strategy with potential to curb new infections and improve access worldwide.

HIV protection with just two shots a year: FDA approves Gilead drug Lenacapavir, to be sold as Yeztugo, has potential to bring AIDS pandemic to heel but faces Trump-era obstacles ...